Subscribe to RSS
Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center ExperienceFundingNone.
Background Peripherally inserted central venous catheters are now widely used in cancer patients who require long-term treatment, for delivering multiple infusates. We aimed to evaluate the overall use of peripherally inserted central catheter (PICC) line in cancer patients, with the objective to study the demographic profile, complications, and safety related to PICC line in cancer patients.
Methods All the patients undergoing treatment for hematological and solid malignancies with PICC line inserted at the Healthcare Global Hospital during the study were evaluated prospectively. The complications related to PICC and its safety were analyzed.
Results Five hundred PICCs were inserted over a period of 2 years to 8 months for a total of 62,440 catheter days (mean of 24 days, i.e., 4.2 months, range: 1–434 days). The most common indication for PICC was for delivering chemotherapy (100%). Of these, 51 (10.2%) PICCs had complications at the rate of 0.82/1000 PICC days, and hence, 41 PICCs were removed. Hematological malignancies had more complications as compared with those with solid malignancies.
Conclusions PICCs are comparatively safe method for the central venous access in cancer patients.
15 June 2021 (online)
© 2020. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Hoshal Jr VL. Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg 1975; 110 (05) 644-646
- 2 Bishop L, Dougherty L, Bodenham A. et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol 2007; 29 (04) 261-278
- 3 Chu FS, Cheng VC, Law MW, Tso WK. Efficacy and complications in peripherally inserted central catheter insertion: a study using 4-Fr non-valved catheters and a single infusate. Australas Radiol 2007; 51 (05) 453-457
- 4 Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care (Engl) 2006; 15 (04) 342-347
- 5 Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 2002; 20 (15) 3276-3281
- 6 Chaitowitz I, Heng R, Bell K. Managing peripherally inserted central catheter-related venous thrombosis: how I do it. Australas Radiol 2006; 50 (02) 132-135
- 7 Haider G, Kumar S, Salam B, Masood N, Jamal A, Rasheed YA. Determination of complication rate of PICC lines in oncological patients. J Pak Med Assoc 2009; 59 (10) 663-667